These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23836962)

  • 1. Topical rebamipide improves the ocular surface in mild lagophthalmos.
    Itakura M; Itakura H; Kashima T; Akiyama H; Kishi S
    Clin Ophthalmol; 2013; 7():1333-8. PubMed ID: 23836962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebamipide (OPC-12759) in the treatment of dry eye: a randomized, double-masked, multicenter, placebo-controlled phase II study.
    Kinoshita S; Awamura S; Oshiden K; Nakamichi N; Suzuki H; Yokoi N;
    Ophthalmology; 2012 Dec; 119(12):2471-8. PubMed ID: 23009892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, multicenter phase 3 study comparing 2% rebamipide (OPC-12759) with 0.1% sodium hyaluronate in the treatment of dry eye.
    Kinoshita S; Oshiden K; Awamura S; Suzuki H; Nakamichi N; Yokoi N;
    Ophthalmology; 2013 Jun; 120(6):1158-65. PubMed ID: 23490326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical rebamipide improves lid wiper epitheliopathy.
    Itakura H; Kashima T; Itakura M; Akiyama H; Kishi S
    Clin Ophthalmol; 2013; 7():2137-41. PubMed ID: 24204116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
    Yamane M; Ogawa Y; Fukui M; Kamoi M; Saijo-Ban Y; Yaguchi S; Mukai S; Kawakita T; Simmura S; Tsubota K
    Optom Vis Sci; 2015 Apr; 92(4 Suppl 1):S25-32. PubMed ID: 25785527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of persistent corneal erosion after administration of topical rebamipide.
    Kashima T; Akiyama H; Miura F; Kishi S
    Clin Ophthalmol; 2012; 6():1403-6. PubMed ID: 22969286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of topical 2% rebamipide ophthalmic suspension in dry eye disease at tertiary care centre.
    Jain K; Jaju M; Yadav D
    Indian J Ophthalmol; 2023 Apr; 71(4):1598-1602. PubMed ID: 37026308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of rebamipide 2% ophthalmic solution in the treatment of dry eyes.
    Shrivastava S; Patkar P; Ramakrishnan R; Kanhere M; Riaz Z
    Oman J Ophthalmol; 2018; 11(3):207-212. PubMed ID: 30505109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Rebamipide Ophthalmic Suspension on Intraocular Light Scattering for Dry Eye After Corneal Refractive Surgery.
    Igarashi A; Kamiya K; Kobashi H; Shimizu K
    Cornea; 2015 Aug; 34(8):895-900. PubMed ID: 26020821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and relevant factors of 2% rebamipide ophthalmic suspension treatment in dry eye.
    Ueda K; Matsumiya W; Otsuka K; Maeda Y; Nagai T; Nakamura M
    BMC Ophthalmol; 2015 Jun; 15():58. PubMed ID: 26048396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye.
    Kinoshita S; Awamura S; Nakamichi N; Suzuki H; Oshiden K; Yokoi N;
    Am J Ophthalmol; 2014 Mar; 157(3):576-83.e1. PubMed ID: 24246575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semi-fluorinated Alkane Eye Drops Reduce Signs and Symptoms of Evaporative Dry Eye Disease After Cataract Surgery.
    Son HS; Yildirim TM; Khoramnia R; Poompokawat P; Knorz MC; Auffarth GU
    J Refract Surg; 2020 Jul; 36(7):474-480. PubMed ID: 32644170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvements in Signs and Symptoms of Dry Eye after Instillation of 2% Rebamipide.
    Igarashi T; Fujita M; Yamada Y; Kobayashi M; Fujimoto C; Takahashi H; Igarashi T; Nakano Y; Suzuki H; Takahashi H
    J Nippon Med Sch; 2015; 82(5):229-36. PubMed ID: 26568389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal.
    Kashima T; Itakura H; Akiyama H; Kishi S
    Clin Ophthalmol; 2014; 8():1003-10. PubMed ID: 24940041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft Versus Host Disease-Associated Dry Eye: Role of Ocular Surface Mucins and the Effect of Rebamipide, a Mucin Secretagogue.
    Shamloo K; Barbarino A; Alfuraih S; Sharma A
    Invest Ophthalmol Vis Sci; 2019 Nov; 60(14):4511-4519. PubMed ID: 31675422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tear Osmolarity, Break-up Time and Schirmer's Scores in Parkinson's Disease.
    Söğütlü Sarı E; Koç R; Yazıcı A; Şahin G; Çakmak H; Kocatürk T; Ermiş SS
    Turk J Ophthalmol; 2015 Aug; 45(4):142-145. PubMed ID: 27800221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain.
    Ozen S; Ozer MA; Akdemir MO
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1173-1177. PubMed ID: 28299439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Rebamipide on Ocular Surface Disorders Induced by Latanoprost and Timolol in Glaucoma Patients.
    Tokuda N; Kitaoka Y; Matsuzawa A; Miyamoto J; Sakae S; Munemasa Y; Takagi H
    J Ophthalmol; 2015; 2015():689076. PubMed ID: 26064674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye.
    Stonecipher KG; Torkildsen GL; Ousler GW; Morris S; Villanueva L; Hollander DA
    Clin Ophthalmol; 2016; 10():887-95. PubMed ID: 27257373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the severity of keratitis sicca with videokeratoscopic indices.
    de Paiva CS; Lindsey JL; Pflugfelder SC
    Ophthalmology; 2003 Jun; 110(6):1102-9. PubMed ID: 12799233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.